Dina Ragab
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- Rheumatoid Arthritis Research and Therapies 3
- Folate and B Vitamins Research 1
-
- Hepatitis C virus research 4
- Co-authors
- Ramy Salem (5 shared papers)Mohamed Taeimah (1 shared paper)Rasha Khattab (1 shared paper)Dina H. Salama (1 shared paper)Rania A. El-Farrash (1 shared paper)Darragh Duffy (1 shared paper)Gamal Esmat (1 shared paper)Matthew L. Albert (1 shared paper)
- Journals
- Cytokine (3 papers)Pediatric Research (1 paper)Virology Journal (1 paper)Frontiers in Immunology (1 paper)Clinical Otolaryngology (1 paper)
- Partner nations
- EgyptUnited StatesFrance
In The Last Decade
Dina Ragab
19 papers receiving 1.3k citations
Dina Ragab's Hit Papers
Peers
Comparison fields: 5 of 120
- Infectious Diseases 642
- Neurology 330
- Biological Psychiatry 28
- Obstetrics and Gynecology 66
- Immunology 183
Countries citing papers authored by Dina Ragab
This map shows the geographic impact of Dina Ragab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Ragab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Ragab more than expected).
Fields of papers citing papers by Dina Ragab
This network shows the impact of papers produced by Dina Ragab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Ragab. The network helps show where Dina Ragab may publish in the future.
Co-authors
The 25 scholars most cited alongside Dina Ragab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The COVID-19 Cytokine Storm; What We Know So Far Hit paper breakdown → | 2020 | 1175 |
| 2 | 2019 | 56 | |
| 3 | 2016 | 32 | |
| 4 | 2013 | 25 | |
| 5 | 2018 | 22 | |
| 6 | 2016 | 17 | |
| 7 | 2016 | 16 | |
| 8 | 2022 | 7 | |
| 9 | 2017 | 3 | |
| 10 | 2023 | 3 | |
| 11 | 2020 | 2 | |
| 12 | 2021 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2025 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2014 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2020 | 1 | |
| 19 | Krebs von den Lungen-6, a promising marker in evaluating the severity of interstitial lung disease in Egyptian rheumatoid arthritis patients. | 2021 | 1 |
| 20 | 2023 | 0 |
About Dina Ragab
Dina Ragab is a scholar working on Rheumatology, Hepatology, Epidemiology, Immunology and Infectious Diseases, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (4 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Endometriosis Research and Treatment (2 papers), T-cell and B-cell Immunology (2 papers), Uterine Myomas and Treatments (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Folate and B Vitamins Research (1 paper) and Organ Transplantation Techniques and Outcomes (1 paper). The work is most often cited by research in Infectious Diseases (642 citations), Neurology (330 citations), Biological Psychiatry (28 citations), Obstetrics and Gynecology (66 citations) and Immunology (183 citations). Dina Ragab has collaborated with scholars based in Egypt, United States and France. Frequent co-authors include Ramy Salem, Mohamed Taeimah, Rasha Khattab, Dina H. Salama, Rania A. El-Farrash, Darragh Duffy, Gamal Esmat, Matthew L. Albert, Melissa E. Laird and Wagdi Elkashef. Their work appears in journals such as Cytokine, Pediatric Research, Virology Journal, Frontiers in Immunology and Clinical Otolaryngology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.